Korro Bio, Inc. (KRRO)
KRRO Stock Price Chart
Explore Korro Bio, Inc. interactive price chart. Choose custom timeframes to analyze KRRO price movements and trends.
KRRO Company Profile
Discover essential business fundamentals and corporate details for Korro Bio, Inc. (KRRO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
3 Oct 2019
Employees
112.00
Website
https://www.korrobio.comCEO
Ram Aiyar
Description
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
KRRO Financial Timeline
Browse a chronological timeline of Korro Bio, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$1.34, while revenue estimate is $214.29k.
Earnings released on 7 May 2026
EPS came in at -$1.69 falling short of the estimated -$1.60 by -5.62%.
Earnings released on 12 Mar 2026
EPS came in at -$5.32 falling short of the estimated -$1.93 by -175.65%, while revenue for the quarter reached $1.30m , beating expectations by +85.71%.
Earnings released on 12 Nov 2025
EPS came in at -$1.92 surpassing the estimated -$2.61 by +26.44%, while revenue for the quarter reached $1.09m , beating expectations by +156.47%.
Earnings released on 12 Aug 2025
EPS came in at -$2.74 falling short of the estimated -$2.54 by -7.87%, while revenue for the quarter reached $1.46m , beating expectations by +355.14%.
Earnings released on 7 May 2025
EPS came in at -$2.49 surpassing the estimated -$2.60 by +4.23%, while revenue for the quarter reached $2.55m , beating expectations by +497.33%.
Earnings released on 18 Mar 2025
EPS came in at -$2.26 surpassing the estimated -$2.33 by +3.00%, while revenue for the quarter reached $2.27m .
Earnings released on 12 Nov 2024
EPS came in at -$2.26 surpassing the estimated -$2.55 by +11.37%.
Earnings released on 13 Aug 2024
EPS came in at -$2.43 falling short of the estimated -$2.40 by -1.25%.
Earnings released on 14 May 2024
EPS came in at -$2.44 falling short of the estimated -$2.36 by -3.39%.
Earnings released on 29 Mar 2024
EPS came in at -$25.65 falling short of the estimated -$2.36 by -986.86%.
Stock split effective on 6 Nov 2023
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 2 Nov 2023
EPS came in at -$15.50 surpassing the estimated -$17.73 by +12.58%.
Earnings released on 10 Aug 2023
EPS came in at -$0.30 surpassing the estimated -$0.44 by +31.82%.
Earnings released on 12 May 2023
EPS came in at -$0.55 falling short of the estimated -$0.39 by -41.03%.
Earnings released on 30 Dec 2022
EPS came in at -$3.21 surpassing the estimated -$31.55 by +89.82%.
Earnings released on 29 Sept 2022
EPS came in at -$3.74 surpassing the estimated -$28.50 by +86.88%.
Earnings released on 30 Jun 2022
EPS came in at -$30.43 surpassing the estimated -$33.17 by +8.26%.
Earnings released on 31 Mar 2022
EPS came in at -$33.59 .
Earnings released on 30 Dec 2021
EPS came in at -$31.07 surpassing the estimated -$31.80 by +2.28%.
Earnings released on 29 Sept 2021
EPS came in at -$36.51 .
KRRO Stock Performance
Access detailed KRRO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
